NCT03864796View on ClinicalTrials.gov

Role of CD11a in Pathogenesis of Primary ITP and Effect of Immunosuppressive Therapy on Its Level

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

May 1, 2020

Study Completion Date

January 1, 2021

Conditions
Idiopathic Thrombocytopenic Purpura
Trial Locations (1)

Unknown

Mona, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03864796 - Role of CD11a in Pathogenesis of Primary ITP and Effect of Immunosuppressive Therapy on Its Level | Biotech Hunter | Biotech Hunter